Wed, 5th February 2025

4:32 pm

Dividend Disbursement

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.

Thu, 23rd January 2025

10:05 am

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.62 for October-December 2024 as against Tk. 0.60 for October-December 2023; EPS was Tk. 1.32 for July-December 2024 as against Tk. 1.20 for July-December 2023. NOCFPS was Tk. (19.54) for July-December 2024 as against Tk. (5.61) for July-December 2023. NAV per share was Tk. 12.58 as on December 31, 2024 and Tk. 12.26 as on June 30, 2024.

Thu, 16th January 2025

4:31 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 22, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.

Sun, 29th December 2024

4:32 pm

Qualified Opinion & Emphasis of Matter

The auditor of the company has given the "Qualified Opinion" & "Emphasis of Matter" paragraph in the auditor?s report for the year ended June 30, 2024. To view the details please visit: https://www.dsebd.org/Auditors_opinion/2024/Ambee_2024.pdf

Mon, 2nd December 2024

12:45 pm

Resumption after Record date

Trading of the shares of the company will resume on 03.12.2024.

Sun, 1st December 2024

12:59 pm

Suspension for Record Date

Trading of the shares of the company will remain suspended on record date i.e., 02.12.2024.

Wed, 27th November 2024

11:40 am

Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 28.11.2024 to 01.12.2024 and trading of the shares will remain suspended on record date i.e., 02.12.2024.

Sun, 17th November 2024

10:04 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.70 for July-September 2024 as against Tk. 0.60 for July-September 2023; NOCFPS was Tk. (6.43) for July-September 2024 as against Tk. (0.49) for July-September 2023. NAV per share was Tk. 12.96 as on September 30, 2024 and Tk. 12.26 as on June 30, 2024.

Mon, 11th November 2024

10:04 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (11.11.2024) following its corporate declaration.

Mon, 11th November 2024

10:04 am

Dividend Declaration

The Board of Directors has recommended 10% Cash Dividend for the year ended June 30, 2024. Date of AGM: 24.12.2024, Time: 11:00 AM, Venue: Online/Digital Platform; 184/1, Tejgaon Industrial Area, Dhaka-1208. Record Date: 02.12.2024. The Company has also reported EPS of Tk. 4.03, NAV per share of Tk. 12.26 and NOCFPS of Tk. (27.47) for the year ended June 30, 2024 as against Tk. 3.79, Tk. 9.73 and Tk. (14.68) respectively for the year ended June 30, 2023.

Sun, 10th November 2024

2:25 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2024.

Tue, 5th November 2024

10:54 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 10, 2024 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2024.

Sun, 7th July 2024

10:15 am

Credit Rating Result

ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A" in the long term and "ST-2" in the short term along with Stable outlook in consideration of audited financials of the company up to June 30, 2023 and unaudited financials up to the period ending March 31, 2024 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Mon, 29th April 2024

10:04 am

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.80 for January-March 2024 as against Tk. 0.70 for January-March 2023; EPS was Tk. 2.00 for July 2023-March 2024 as against Tk. 1.34 for July 2022-March 2023. NOCFPS was Tk. (12.21) for July 2023-March 2024 as against Tk. 0.38 for July 2022-March 2023. NAV per share was Tk. 10.23 as on March 31, 2024 and Tk. 9.73 as on June 30, 2023.

Tue, 23rd April 2024

1:09 pm

Dividend Disbursement

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2023 to the respective shareholders.

Sun, 21st April 2024

4:31 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2024 at 03:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2024.

Mon, 29th January 2024

10:04 am

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.60 for October-December 2023 as against Tk. 0.35 for October-December 2022; EPS was Tk. 1.20 for July-December 2023 as against Tk. 0.60 for July-December 2022. NOCFPS was Tk. (5.61) for July-December 2023 as against Tk. 7.69 for July-December 2022. NAV per share was Tk. 9.43 as on December 31, 2023 and Tk. 9.73 as on June 30, 2023.

Sun, 21st January 2024

12:54 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2024 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2023.

Thu, 23rd November 2023

12:35 pm

Resumption after Record date

Trading of the shares of the company will resume on 26.11.2023.

Wed, 22nd November 2023

11:55 am

Suspension for Record Date

Trading of the shares of the company will remain suspended on record date i.e., 23.11.2023.

Mon, 20th November 2023

1:04 pm

Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 21.11.2023 to 22.11.2023 and trading of the shares will remain suspended on record date i.e., 23.11.2023.

Wed, 15th November 2023

12:19 pm

Qualified Opinion

The auditor of the company has given the "Qualified Opinion" paragraph in the Auditor's Report of the company for the year ended June 30, 2023. To view the details, please visit: https://www.dsebd.org/assets/pdf/Qualified%20Opinion%20of%20Ambee%20Pharmaceuticals%20PLC%20for%20the%20year%20ended%20on%2030%20June%202023.pdf

Wed, 15th November 2023

10:04 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.60 for July-September 2023 as against Tk. 0.25 for July-September 2022; NOCFPS was Tk. (0.49) for July-September 2023 as against Tk. 4.34 for July-September 2022. NAV per share was Tk. 10.33 as on September 30, 2023 and Tk. 9.73 as on June 30, 2023.

Thu, 9th November 2023

12:15 pm

Change of AGM Time

Refer to their earlier news disseminated by DSE on 05.11.2023 regarding dividend declaration and increase of paid up capital, the company has further informed that the time of AGM will be 4:00 PM instead of 11:00 AM. The date and venue of the AGM will remain unchanged.

Wed, 8th November 2023

4:32 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.

Sun, 5th November 2023

10:04 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (05.11.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.

Sun, 5th November 2023

10:04 am

Dividend Declaration and increase of paid up capital

The Board of Directors has recommended 15% Cash Dividend for the year ended June 30, 2023. Date of AGM: 14.12.2023, Time: 11:00 AM, Venue: Digital Platform. Record date: 23.11.2023. The Company has also reported EPS of Tk. 3.79, NAV per share of Tk. 9.73 and NOCFPS of Tk. (14.68) for the year ended June 30, 2023 as against Tk. 3.36, Tk. 21.96 and Tk. (30.49) respectively for the year ended June 30, 2022. The Board also recommended paid up capital to be increased from TK. 2.40 Crore to TK. 30.00 Crore.

Thu, 26th October 2023

4:32 pm

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 02, 2023 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.

Mon, 2nd October 2023

11:45 am

Query Response

In response to a DSE query dated September 27, 2023, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike and increase in volume of shares.

Tue, 8th August 2023

4:31 pm

Name Change of the Company

Dhaka Stock Exchange Limited (DSE) has approved the proposed name change of the Company. Accordingly, the name of the Company will be 'Ambee Pharmaceuticals PLC' instead of 'Ambee Pharmaceuticals Ltd.' with effect from August 09, 2023. Other things (except name) will remain unchanged.

Mon, 17th April 2023

10:04 am

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.70 for January-March 2023 as against Tk. 0.40 for January-March 2022; EPS was Tk. 1.34 for July 2022-March 2023 as against Tk. 0.74 for July 2021-March 2022. NOCFPS was Tk. 0.38 for July 2022-March 2023 as against Tk. 2.18 for July 2021-March 2022. NAV per share was Tk. 19.02 as on March 31, 2023 and Tk. 21.96 as on June 30, 2022.

Wed, 12th April 2023

10:15 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 16, 2023 at 2:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.

Mon, 3rd April 2023

10:45 am

Appointment of Company Secretary

The company has informed that the Board of Directors has approved Mr. Mohammad Amir Hossain as Company Secretary of the company with effect from April 01, 2023.

Mon, 27th March 2023

3:32 pm

Appointment of Chief Financial Officer

The company has informed that the Board of Directors has approved Mr. A.K.M. Khairul Aziz as Chief Financial Officer of the company with effect from March 23, 2023.

Sun, 5th February 2023

10:05 am

Dividend Disbursement

The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2022 to the respective shareholders.

Thu, 26th January 2023

10:05 am

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.35 for October-December, 2022 as against Tk. 0.24 for October-December, 2021; EPS was Tk. 0.60 for July-December, 2022 as against Tk. 0.34 for July-December, 2021. NOCFPS was Tk. 7.69 for July-December, 2022 as against Tk. 4.21 for July-December, 2021. NAV per share was Tk. 21.56 as on December 31, 2022 and Tk. 21.96 as on June 30, 2022. Reasons for Deviation in NOCFPS: NOCFPS increased due to decrease of payments for cost and expenses.

Thu, 19th January 2023

1:35 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 25, 2023 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.

Sun, 1st January 2023

10:40 am

BSEC rejected issuance of 20% Stock Dividend

Refer to their earlier news disseminated by DSE on 23.11.2022 regarding Dividend Declaration (Additional Information), the company has further informed that the decision regarding raising of paid-up capital through issuance of 20% stock dividend for the year ended June 30, 2022 has not been approved by Bangladesh Securities and Exchange Commission.

Mon, 12th December 2022

10:34 am

Resumption after record date

Trading of the shares of the Company will resume on 13.12.2022 after record date.

Sun, 11th December 2022

12:45 pm

Suspension for Record date

Trading of the shares of the Company will remain suspended on record date i.e., 12.12.2022.

Sun, 11th December 2022

10:05 am

Regarding record date for entitlement of Stock Dividend

Refer to their earlier news disseminated by DSE on 22.11.2022 regarding dividend declaration and increase of Authorized Capital, the company has further informed that they made an application to BSEC for issuance of 20% Stock dividend but they have not received approval yet. So they will notify another record date later for entitlement of Stock Dividend if they get approval from BSEC. However, the record date as on 12.12.2022 will be applicable for entitlement of 10% Cash dividend.

Wed, 7th December 2022

12:14 pm

Spot News

Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 08.12.2022 to 11.12.2022. Trading of the shares will remain suspended on record date i.e., 12.12.2022.

Mon, 5th December 2022

1:54 pm

Qualified Opinion

(Continuation news of AMBEEPHA): Hence, there is a shortfall in the dividend bank account. This is a non-compliance of the section 28 (1) of Dhaka Stock Exchange (Listing) Regulations, 2015. (end)

Mon, 5th December 2022

1:54 pm

Qualified Opinion

(Continuation news of AMBEEPHA): Tk. 2,356,352 as Unclaimed Dividend as at 30.06.2022. The amount has arrived at after payment of Tk. 1,500,000 to the Capital Market Stabilization Fund (CMSF) as per directive of Bangladesh Securities and Exchange Commission (BSEC) No. SEC/SRMlC/165-2020/part-1/202 dated 25 August 2021. The designated bank account for dividend has shown a balance of Tk. 153,954 as at 30.06.2022. (cont.4)

Mon, 5th December 2022

1:54 pm

Qualified Opinion

(Continuation news of AMBEEPHA): The amount is carried forward from earlier years. As no Financial Statement of Provident Fund was made available to us, so we are not sure whether there is any forfeited fund returned to company's account from the contributory provident fund as per notification no. 179/FRC/FRM/2020/2, dated July 07, 2020 of the Financial Reporting Council (FRC). 3. As disclosed in note # 20.00, the company has shown an amount of (cont.3)

Mon, 5th December 2022

1:54 pm

Qualified Opinion

(Continuation news of AMBEEPHA): As per section 234 (b) of Labour Act, 2006 the company should pay the amount to the WPF & WWF not later than nine months from the end of the respective year. Incase of failure penalty as per section 236 may be imposed. However, for utilization of the fund the company provided interest as per section 240. 2. As disclosed in note # 17.02, the company has shown Tk. 1,916,358 as Payable to Provident Fund. (cont.2)

Mon, 5th December 2022

1:54 pm

Qualified Opinion

The auditor of the Ambee Pharmaceuticals Ltd. has given the "Qualified Opinion" paragraph in the Auditor's Report for the year ended June 30, 2022. Basis for Qualified Opinion: 1. As disclosed in note # 19.00, the company has shown Tk. 10,459,676 as liabilities for WPF & WWF which includes prior year's amount of Tk. 9,948,826. Out of the prior year's amount an amount of Tk. 1,144,988 has been paid by the company. (cont.1)

Mon, 28th November 2022

10:04 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.25 for July-September 2022 as against Tk. 0.10 for July-September 2021; NOCFPS was Tk. 4.34 for July-September 2022 as against Tk. 8.37 for July-September 2021. NAV per share was Tk. 22.20 as on September 30, 2022 and Tk. 21.96 as on June 30, 2022.

Wed, 23rd November 2022

11:40 am

Update of Information

The Company has requested the Shareholders who changed/amended their e-mail addresses or opened new e-mail addresses after the Record Date to e-mail the details to cs@ambeepharma.com along with full name, Folio/BO ID to receive the digital platform meeting invitation. The Company has also requested the Shareholders to notify 12-digit Taxpayer's Identification Number (E-TIN) through their respective Depository Participants.

Wed, 23rd November 2022

10:00 am

Dividend Declaration (Additional Information)

(Continuation news of AMBEEPHA): regulatory requirement. ii) They have declared the Stock Dividend from the profit of Financial Year 2021- 2022. iii) They have not declared such stock dividend or bonus shares from capital reserve or revaluation reserve or any unrealized gain or out of profit earned prior to incorporation of the company or through reducing paid up capital or through doing anything so that the post-dividend retained earnings become negative or a debit balance. (end)

Wed, 23rd November 2022

10:00 am

Dividend Declaration (Additional Information)

The company has further informed that the stock dividend declared by them is subject to the approval of Bangladesh Securities and Exchange Commission as per BSEC Notification No. BSEC/CMRRCD/2009-193/46/Admin/138 dated October 03, 2022. Record date: 12.12.2022. The company has also informed that i) The reason for the declaration of Stock Dividend is to raise minimum paid-up capital of Tk. 30.00 crore as per (cont.)

Tue, 22nd November 2022

10:55 am

Dividend Declaration (Correction News)

(Correction News): The correction news will be Conditions 2 and 3(c) of BSEC Notification instead of Conditions 2 and 3(a) of BSEC Notification. Other information will remain unchanged.

Tue, 22nd November 2022

10:10 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (22.11.2022) following its corporate declaration. However, as per the BSEC Order No. BSEC/CMRRCD/2001-07/39 dated July 28, 2022, the floor price shall be applicable accordingly.

Tue, 22nd November 2022

10:10 am

Dividend Declaration and Increase of Authorized Capital

(Continuation news of AMBEEPHA): Ambee Pharmaceuticals PLC as to amend Clause 1 of Memorandum of Association of the Company. ii) To increase the Authorized Capital of the Company from Tk. 2.50 crore to Tk. 30.00 crore and to amend the Clause 5 and Article 4 and Article 53 of the Memorandum and Articles of Association of the Company. (end)

Tue, 22nd November 2022

10:10 am

Dividend Declaration and Increase of Authorized Capital

(Continuation news of AMBEEPHA): The Company has also reported EPS of Tk. 3.36, NAV per share of Tk. 21.96 and NOCFPS of Tk. (30.49) for the year ended June 30, 2022 as against Tk. (5.42), Tk. 18.68 and Tk. (2.27) respectively for the same period of the previous year. The company has further informed that the following agenda as special business, among others, will be placed for approval in the AGM: i) To change the name of the Company from Ambee Pharmaceuticals Limited to (cont.2)

Tue, 22nd November 2022

10:10 am

Dividend Declaration and Increase of Authorized Capital

The Board of Directors has recommended 10% Cash and 20% Stock dividend for the year ended June 30, 2022. DSE has sent a query letter to the company as they have not complied Conditions 2 and 3(a) of BSEC Notification No.- BSEC/CMRRCD/2009-193/46/Admin/138 dated October 03, 2022 regarding declaration of stock dividend. Date of AGM: 31.12.2022, Time: 11:00 AM, Venue: Digital Platform. Record date: will be notified later on. (cont.1)

Tue, 22nd November 2022

10:00 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 27, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2022.

Sun, 20th November 2022

11:19 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 21, 2022 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2022.

Tue, 12th July 2022

10:54 am

Appointment of Managing Director

The Company has informed that Ms. Kazi Tanzzina Ferdous, has been appointed as the Managing Director of the Company.

Thu, 28th April 2022

10:05 am

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.40 for January-March 2022 as against Tk. 0.30 for January-March 2021; EPS was Tk. 0.74 for July 2021-March 2022 as against Tk. 0.65 for July 2020-March 2021. NOCFPS was Tk. 2.18 for July 2021-March 2022 as against Tk. 3.89 for July 2020-March 2021. NAV per share was Tk. 19.42 as on March 31, 2022 and Tk. 18.68 as on June 30, 2021.

Thu, 21st April 2022

2:00 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 27, 2022 at 2:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2022.

Wed, 2nd March 2022

10:19 am

Credit Rating Result

Bangladesh Rating Agency Limited (BDRAL) has assigned the Company as "A-" for long term and "ST-3" for short term with developing outlook in consideration of audited financials of the Company up to June 30, 2021, unaudited financials up to December 31, 2021 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Sun, 30th January 2022

10:04 am

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.24 for October-December, 2021 as against Tk. 0.20 for October-December, 2020; EPS was Tk. 0.34 for July-December, 2021 as against Tk. 0.35 for July-December, 2020. NOCFPS was Tk. 4.21 for July-December, 2021 as against Tk. 0.54 for July-December, 2020. NAV per share was Tk. 18.92 as on December 31, 2021 and Tk. 18.68 as on June 30, 2021.

Mon, 24th January 2022

10:10 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 27, 2022 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2021.

Sun, 5th December 2021

10:45 am

Resumption after record date

Trading of the shares of the Company will resume on 06.12.2021 after record date.

Thu, 2nd December 2021

11:34 am

Suspension for Record date

Trading of the shares of the Company will remain suspended on record date i.e., 05.12.2021.

Tue, 30th November 2021

11:15 am

Spot News

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle from 01.12.2021 to 02.12.2021. Trading of the shares of the Company will remain suspended on record date i.e., 05.12.2021.

Tue, 23rd November 2021

10:04 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.10 for July-September 2021 as against Tk. 0.15 for July-September 2020; NOCFPS was Tk. 8.37 for July-September 2021 as against Tk. 0.68 for July-September 2020. NAV per share was Tk. 18.79 as on September 30, 2021 and Tk. 18.68 as on June 30, 2021.

Thu, 18th November 2021

4:46 pm

Emphasis of Matter

(Continuation news of AMBEEPHA): Physical counting of cash in hand at Head Office for Tk. 13,548 and Factory for Tk. 4,357 only was done by the management at the year-end. (end)

Thu, 18th November 2021

4:46 pm

Emphasis of Matter

The auditor of the Ambee Pharmaceuticals Ltd.has given the "Emphasis of matter" paragraphs in the Auditor's Report for the year ended on 30 June, 2021. Emphasis of Matter: In forming our opinion on the Financial Statements, which is not modified, we considered the following matter and the fact that as per note # 10.01, the company reported an amount of Tk. 12,796,385 as cash in hand. (cont.1)

Thu, 18th November 2021

4:46 pm

Qualified Opinion

(Continuation news of AMBEEPHA): Regulations, 2015 and in compliance with clause 3 (vii) of the Bangladesh Securities and Exchange Commission (BSEC) Directive No. BSEC/CMRRCD/2021-386/03, dated 14 January 2021. (end)

Thu, 18th November 2021

4:46 pm

Qualified Opinion

(Continuation news of AMBEEPHA): July 07, 2020 of the Financial Reporting Council (FRC). 3. As disclosed in note # 21.00, the company has shown Tk. 3,856,352 as Unclaimed Dividend. As the company has no designated bank account for dividend, so we are not sure whether the dividend was paid to the shareholders within the stipulated time as per section 28(1) of Dhaka Stock Exchange (Listing) (cont.3)

Thu, 18th November 2021

4:46 pm

Qualified Opinion

(Continuation news of AMBEEPHA): later than nine months from the end of the respective year. 2. As disclosed in note # 18.02, the company has shown Tk. 1,916,358 as Payable to Provident Fund. The amount is carried forward from earlier years. As no financial statement of Provident Fund was made available to us, so we are not sure whether there is any forfeited fund returned to company's account from the contributory provident fund as per notification no. 179/FRC/FRM/2020/2, dated (cont.2)

Thu, 18th November 2021

4:46 pm

Qualified Opinion

The auditor of the Ambee Pharmaceuticals Ltd. has given the "Qualified Opinion" paragraphs in the Auditor's Report for the year ended on 30 June, 2021. Basis for Qualified Opinion: 1. As disclosed in note # 20.00, the company has shown Tk. 9,948,826 as liabilities for WPF & WWF which includes prior year's amount of Tk. 9,127,363 that has not been paid by the company to the Fund. As per section 234 (b) of Labour Act, 2006 the company should pay the amount to the WPF & WWF not (cont.1)

Thu, 18th November 2021

10:05 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 22, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

Sun, 14th November 2021

4:47 pm

Dividend Declaration (Additional Information)

The Company has further informed that NOCFPS of Tk. (2.27) instead of Tk. (2.77) for the year ended on June 30, 2021. All other information will remain unchanged.

Sun, 14th November 2021

10:05 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (14.11.2021) following its corporate declaration.

Sun, 14th November 2021

10:05 am

Dividend Declaration

The Board of Directors has recommended No dividend for the year ended on June 30, 2021. Date of AGM: 28.12.2021, Time: 11:00 AM, Venue: digital platform. Record date: 05.12.2021. The Company has also reported EPS of Tk. (5.42), NAV per share of Tk. 18.68 and NOCFPS of Tk. (2.77) for the year ended on June 30, 2021 as against Tk. 1.52, Tk. 24.10 and Tk. (4.99) respectively for the same period of the previous year.

Sun, 7th November 2021

10:05 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 11, 2021 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

Thu, 16th September 2021

11:29 am

Dividend Disbursement

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2020 to the respective shareholders.

Mon, 13th September 2021

1:49 pm

Query Response

In response to a DSE query dated September 12, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

Wed, 18th August 2021

10:05 am

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.30 for January-March 2021 as against Tk. 0.75 for January-March 2020; EPS was Tk. 0.65 for July 2020-March 2021 as against Tk. 2.38 for July 2019-March 2020. NOCFPS was Tk. 3.89 for July 2020-March 2021 as against Tk. 0.09 for July 2019-March 2020. NAV per share was Tk. 23.25 as on March 31, 2021 and Tk. 24.10 as on June 30, 2020.

Wed, 18th August 2021

10:05 am

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.20 for October-December, 2020 as against Tk. 0.88 for October-December, 2019; EPS was Tk. 0.35 for July-December, 2020 as against Tk. 1.63 for July-December, 2019. NOCFPS was Tk. 0.54 for July-December, 2020 as against Tk. 0.07 for July-December, 2019. NAV per share was Tk. 22.95 as on December 31, 2020 and Tk. 24.10 as on June 30, 2020.

Wed, 18th August 2021

10:05 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.15 for July-September 2020 as against Tk. 0.75 for July-September 2019; NOCFPS was Tk. 0.68 for July-September 2020 as against Tk. 0.44 for July-September 2019. NAV per share was Tk. 24.25 as on September 30, 2020 and Tk. 24.10 as on June 30, 2020.

Wed, 11th August 2021

10:05 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on August 17, 2021 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2020, Second Quarter (Q2) period ended on December 31, 2020 & Third Quarter (Q3) period ended on March 31, 2021.

Mon, 28th June 2021

10:15 am

Resumption after record date

Trading of the shares of the Company will resume on 29.06.2021 after record date.

Sun, 27th June 2021

10:45 am

Suspension for Record date

Trading of the shares of the Company will remain suspended on record date i.e., 28.06.2021.

Wed, 23rd June 2021

10:45 am

Spot News

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 24.06.2021 to 27.06.2021. Trading of the shares of the Company will remain suspended on record date i.e., 28.06.2021.

Thu, 17th June 2021

10:05 am

Qualified Opinion & Emphasis of Matter

(Continuation news of AMBEEPHA): the company filed an application to the Hon'ble High Court for condonation of default for not holding the AGM in time. On hearing the petition, the Hon'ble High Court in its' verdict has accepted the condonation petition and directed the company to hold the AGM within eight weeks on receipt of the copy of verdict. However, the company received the verdict on 01-06-2021. (end)

Thu, 17th June 2021

10:05 am

Qualified Opinion & Emphasis of Matter

The auditor of the Ambee Pharmaceuticals Ltd has given the "Qualified Opinion" & "Emphasis of Matter" paragraphs in the Auditor's Report for the year ended on 30 June 2020. Basis for Qualified Opinion: The Company has not disclosed BDT 18,000,000 as VAT payable in their VAT return. Emphasis of matter: Due to some unavoidable circumstances, AGM of the company could not be held in time and accordingly, (cont.)

Tue, 8th June 2021

10:05 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (08.06.2021) following its corporate declaration, however, as per the BSEC Order No. BSEC/CMRRCD/2001-07/04 dated March 19, 2020, the floor price shall be applicable accordingly.

Tue, 8th June 2021

10:05 am

Dividend Declaration

The Board of Directors has recommended 15% cash dividend for the year ended on June 30, 2020. Date of AGM: 13.07.2021, Time: 11:00 AM, Venue: digital platform. Record date: 28.06.2021. The Company has also reported EPS of Tk. 1.52, NAV per share of Tk. 24.10 and NOCFPS of Tk. (4.99) for the year ended on June 30, 2020 as against Tk. 1.40, Tk. 24.09 and Tk. 16.42 respectively for the same period of the previous year.

Mon, 31st May 2021

10:04 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 7, 2021 at 3:15 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2020.

Thu, 24th December 2020

10:05 am

Credit Rating Result

ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A" for long term and "ST-2" for short term with stable outlook in consideration of audited financials of the Company up to June 30, 2019, unaudited financials up to the period ending March 31, 2020 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Thu, 11th June 2020

3:53 pm

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.75 for January-March 2020 as against Tk. 0.85 for January-March 2019; EPS was Tk. 2.38 for July 2019-March 2020 as against Tk. 2.54 for July 2018-March 2019. NOCFPS was Tk. 0.09 for July 2019-March 2020 as against Tk. 3.83 for July 2018-March 2019. NAV per share was Tk. 23.47 as on March 31, 2020 and Tk. 24.09 as on June 30, 2019.

Sun, 7th June 2020

11:46 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on June 11, 2020 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2020.

Thu, 6th February 2020

2:09 pm

Dividend Disbursement

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2019 to the respective shareholders.

Wed, 29th January 2020

4:18 pm

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.88 for October-December, 2019 as against Tk. 0.85 for October-December, 2018; EPS was Tk. 1.63 for July-December, 2019 as against Tk. 1.69 for July-December, 2018. NOCFPS was Tk. 0.07 for July-December, 2019 as against Tk. 5.66 for July-December, 2018. NAV per share was Tk. 22.72 as on December 31, 2019 and Tk. 24.09 as on June 30, 2019.

Thu, 23rd January 2020

3:29 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2020 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2019.

Tue, 17th December 2019

11:31 am

Resumption after record date

Trading of the Shares of the Company will resume on 18.12.2019 after record date.

Sun, 15th December 2019

11:31 am

Suspension for Record Date

Trading of the shares of the Company will remain suspended on record date i.e., 17.12.2019.

Wed, 11th December 2019

11:25 am

Spot News

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 12.12.2019 to 15.12.2019. Trading of the shares of the Company will remain suspended on record date i.e., 17.12.2019.

Sun, 1st December 2019

9:47 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.75 for July-September 2019 as against Tk. 0.84 for July-September 2018; NOCFPS was Tk. 0.44 for July-September 2019 as against Tk. 1.22 for July-September 2018. NAV per share was Tk. 24.84 as on September 30, 2019 and Tk. 24.09 as on June 30, 2019.

Wed, 27th November 2019

9:51 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (27.11.2019) following its corporate declaration.

Wed, 27th November 2019

9:51 am

Dividend Declaration

(Continuation news of AMBEEPHA): NOCFPS increased in this year by Tk. 8.66 due to increase of collection against sales by 3.05% than last year and decrease of operating expenses against sales in this year by 1.07 % than last year. (end)

Wed, 27th November 2019

9:51 am

Dividend Declaration

(Continuation news of AMBEEPHA): The Company has also informed that EPS decreased by Tk. 2.04 due to profit after tax decreased by Tk. 4,896,965.00 this year than last year. During the year earlier year income taxes of Tk. 5,586,300.00 and interest on WPPF Fund of Tk. 940,672.00 which relates to previous year have been charged as expenses for the year resulting decrease of EPS. (cont.2)

Wed, 27th November 2019

9:51 am

Dividend Declaration

The Board of Directors has recommended 30% cash dividend for the year ended on June 30, 2019. Date of AGM: 31.12.2019, Time: 10:00 AM, Venue: Factory Premises, 184/1 Tejgaon Industrial Area, Dhaka-1208. Record date: 17.12.2019. The Company has also reported EPS of Tk. 1.40, NAV per share of Tk. 24.09 and NOCFPS of Tk. 16.42 for the year ended on June 30, 2019 as against Tk. 3.44, Tk. 25.68 and Tk. 7.76 respectively for the same period of the previous year. (cont.1)

Sun, 24th November 2019

3:21 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 28, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

Mon, 18th November 2019

3:39 pm

Credit Rating Result

ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A" for long term and "ST-2" for short term with stable outlook in consideration of audited financials of the Company up to June 30, 2018, unaudited financials up to the period ending March 31, 2019 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Mon, 18th November 2019

3:09 pm

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 26, 2019 at 3:15 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

Sun, 28th April 2019

4:17 pm

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.85 for January-March 2019 as against Tk. 0.95 for January-March 2018; EPS was Tk. 2.54 for July 2018-March 2019 as against Tk. 2.52 for July 2017-March 2018. NOCFPS was Tk. 3.83 for July 2018-March 2019 as against Tk. 3.51 for July 2017-March 2018. NAV per share was Tk. 25.22 as on March 31, 2019 and Tk. 25.68 as on June 30, 2018.

Sun, 21st April 2019

3:52 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2019.

Tue, 29th January 2019

4:08 pm

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.85 for October-December, 2018 as against Tk. 0.82 for October-December, 2017; EPS was Tk. 1.69 for July-December, 2018 as against Tk. 1.57 for July-December, 2017. NOCFPS was Tk. 5.66 for July-December, 2018 as against Tk. 3.46 for July-December, 2017. NAV per share was Tk. 24.38 as on December 31, 2018 and Tk. 25.68 as on June 30, 2018.

Mon, 28th January 2019

10:10 am

Cash Dividend Disbursement

The Company has informed that it has disbursed the cash dividend to the respective shareholders for the year ended on June 30, 2018.

Wed, 23rd January 2019

2:51 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2019 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2018.

Wed, 5th December 2018

9:45 am

Emphasis of Matter

(Continuation news of AMBEEPHA): adjusting cash flows from financing activities resulting decrease in cash generated from operating activities. As a result, net operating cash flow per share of previous year of Taka 10.33 has been reduced to Taka 7.59. This was due to some wrong treatments of debit/credit balances of loan accounts. (end)

Wed, 5th December 2018

9:45 am

Emphasis of Matter

(Continuation news of AMBEEPHA): Tk. 7.76. Net Operating Cash Flow per share for the year 2016-17: Cash flows from net operating activities as per Statement of Cash flows Tk. 18,225,025.00, Weighted average number of Ordinary shares outstanding during the year 2,400,000 and Net Operating Cash Flow per share Tk. 7.59. During the year, previous year's payment for costs, expenses & others in statement of cash flows have been rearranged by increasing Taka 6,573,133.00 and (cont. 3)

Wed, 5th December 2018

9:45 am

Emphasis of Matter

(Continuation news of AMBEEPHA): Cash Flow per share in which previous years' figure of Taka 10.33 has been reduced to Taka 7.59 (reduced 2.74 Taka per share) which was due to wrong treatment of some accounts. Note: 28.00 Net Operating Cash Flow per share for the year 2017-18: Cash flows from net operating activities as per Statement of Cash flows Tk. 18,626,052.00, Weighted average number of Ordinary shares outstanding during the year 2,400,000 and Net Operating Cash Flow per share (cont. 2)

Wed, 5th December 2018

9:45 am

Emphasis of Matter

(Emphasis of Matter): The auditor of the company has given the following "Emphasis of Matter" paragraph in the audit report of the company prepared for the year ended on 30 June 2018. Emphasis of Matter: i) The company has not properly complied with section 234 (l)(b) of Bangladesh Labor Law 2006 (as amended in 2013) of WPPF rules regarding distribution of the fund and interest payable thereon. ii) We refer to note-28 regarding Net Operating (cont. 1)

Tue, 4th December 2018

11:20 am

Resumption after record date

Trading of the shares of the Company will resume on 05.12.2018 after record date.

Mon, 3rd December 2018

12:18 pm

Suspension for Record date

Trading of the shares of the Company will remain suspended on record date i.e., 04.12.2018.

Thu, 29th November 2018

12:48 pm

Spot News

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 02.12.2018 to 03.12.2018. Trading of the shares of the Company will remain suspended on record date i.e., 04.12.2018.

Mon, 26th November 2018

12:35 pm

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares.

Thu, 15th November 2018

10:20 am

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.84 for July-September, 2018 as against Tk. 0.75 for July-September, 2017; NOCFPS was Tk. 1.22 for July-September, 2018 as against Tk. 3.45 for July-September, 2017. NAV per share was Tk. 26.53 as on September 30, 2018 and Tk. 25.68 as on June 30, 2018.

Tue, 13th November 2018

9:48 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (13.11.2018) following its corporate declaration.

Tue, 13th November 2018

9:48 am

Dividend Declaration

The Board of Directors has recommended 30% cash dividend for the year ended on June 30, 2018. Date of AGM: 27.12.2018, Time: 10:00 AM, Venue: 184/1 Tejgaon Industrial Area, Dhaka-1208. Record date: 04.12.2018. The Company has also reported EPS of Tk. 3.44, NAV per share of Tk. 25.68 and NOCFPS of Tk. 7.76 for the year ended on June 30, 2018 as against Tk. 3.02, Tk. 25.24 and Tk. 7.59 respectively for the same period of the previous year.

Sun, 11th November 2018

10:46 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2018.

Mon, 5th November 2018

11:21 am

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 12, 2018 at 3:15 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2018.

Thu, 20th September 2018

9:50 am

Credit Rating Result

ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A" for long term and "ST-2" for short term with stable outlook in consideration of audited financials of the Company up to June 30, 2017, unaudited financials up to the period ending March 31, 2018 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Thu, 19th July 2018

12:42 pm

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Mon, 2nd July 2018

11:38 am

Query Response (Repeat News)

(Repeat News): In response to a DSE query dated June 28, 2018, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares.

Thu, 28th June 2018

2:27 pm

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Mon, 4th June 2018

12:38 pm

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Wed, 25th April 2018

4:00 pm

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.95 for January-March 2018 as against Tk. 0.92 for January-March 2017; EPS was Tk. 2.52 for July 2017-March 2018 as against Tk. 2.32 for July 2016-March 2017. NOCFPS was Tk. 3.51 for July 2017-March 2018 as against Tk. 8.33 for July 2016-March 2017. NAV per share was Tk. 24.76 as on March 31, 2018 and Tk. 25.24 as on June 30, 2017.

Sun, 22nd April 2018

10:23 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 25, 2018 at 3:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2018.

Tue, 17th April 2018

10:08 am

Query Response

In response to a DSE query dated April 16, 2018, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares.

Mon, 26th February 2018

9:52 am

Query Response

In response to a DSE query dated February 22, 2018, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike of shares and increase in trading volume.

Mon, 29th January 2018

4:38 pm

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.82 for October-December, 2017 as against Tk. 0.85 for October-December, 2016; EPS was Tk. 1.57 for July-December, 2017 as against Tk. 1.40 for July-December, 2016. NOCFPS was Tk. 3.46 for July-December, 2017 as against Tk. 5.47 for July-December, 2016. NAV per share was Tk. 23.81 as on December 31, 2017 and Tk. 25.24 as on June 30, 2017.

Tue, 23rd January 2018

3:59 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2018 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2017.

Mon, 22nd January 2018

2:57 pm

Dividend Disbursement

The Company has informed that it has disbursed the cash dividend for the year ended on June 30, 2017 to the respective shareholders' mailing address by courier service.

Mon, 27th November 2017

12:55 pm

Resumption after record date

Trading of the shares of the Company will resume on 28.11.2017 after record date.

Sun, 26th November 2017

1:07 pm

Suspension for Record Date

Trading of the shares of the Company will remain suspended on record date i.e., 27.11.2017.

Wed, 22nd November 2017

1:05 pm

Spot News

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 23.11.2017 to 26.11.2017. Trading of the shares of the Company will remain suspended on record date i.e., 27.11.2017.

Mon, 13th November 2017

4:32 pm

Q1 Financials

(Q1 Un-audited): EPS was Tk. 0.75 for July-September, 2017 as against Tk. 0.55 for July-September, 2016; NOCFPS was Tk. 3.45 for July-September, 2017 as against Tk. 3.35 for July-September, 2016. NAV per share was Tk. 25.99 as on September 30, 2017 and Tk. 25.24 as on June 30, 2017.

Wed, 8th November 2017

10:09 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2017 at 3:30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.

Mon, 6th November 2017

9:55 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (06.11.2017) following its corporate declaration.

Mon, 6th November 2017

9:53 am

Dividend Declaration

The Board of Directors has recommended 30% cash dividend for the year ended on June 30, 2017. Date of AGM: 21.12.2017, Time: 10:00 AM, Venue: 184/1 Tejgaon Industrial Area, Dhaka-1208. Record date: 27.11.2017. The Company has also reported EPS of Tk. 3.02, NAV per share of Tk. 25.24 and NOCFPS of Tk. 10.33 for the year ended on June 30, 2017 which was Tk. 3.41, Tk. 24.82 and Tk. 12.06 respectively for the 18 months period from January 01, 2015 to June 30, 2016.

Mon, 30th October 2017

4:18 pm

Board Meeting schedule under LR 19(1)

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 05, 2017 at 3:15 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.

Wed, 7th June 2017

9:55 am

Credit Rating Result

ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A-" for long term and "ST-2" for short term with stable outlook in consideration of audited financials of the Company up to June 30, 2016, unaudited financials up to the period ending March 31, 2017 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Wed, 26th April 2017

4:27 pm

Q3 Financials

(Q3 Un-audited): EPS was Tk. 0.92 for January-March, 2017 as against Tk. 0.57 for January-March, 2016; EPS was Tk. 2.32 for July, 2016-March, 2017 as against Tk. 2.56 for July, 2015-March, 2016. NOCFPS was Tk. 8.33 for July, 2016-March, 2017 as against Tk. 5.89 for July, 2015-March, 2016. NAV per share was Tk. 24.54 as of March 31, 2017 and Tk. 24.82 as of June 30, 2016.

Thu, 20th April 2017

3:40 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 26, 2017 at 3:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.

Tue, 31st January 2017

4:53 pm

Q2 Financials

(Q2 Un-audited): EPS was Tk. 0.85 for October-December, 2016 as against Tk. 0.61 for October-December, 2015; EPS was Tk. 1.40 for July-December, 2016 as against Tk. 1.99 for July-December, 2015. NOCFPS was Tk. 5.47 for July-December, 2016 as against Tk. 5.69 for July-December, 2015. NAV per share was Tk. 26.22 as of December 31, 2016 and Tk. 24.82 as of June 30, 2016.

Thu, 26th January 2017

4:26 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 31, 2017 at 3:15 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.

Wed, 14th December 2016

1:12 pm

Resumption after record date

Trading of the shares of the Company will resume on 15.12.2016 after record date.

Mon, 12th December 2016

3:26 pm

Suspension for Record Date

Trading of the shares of the Company will remain suspended on record date i.e., 14.12.2016.

Thu, 8th December 2016

6:00 pm

Spot market trading suspended

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 11.12.2016 to 12.12.2016. Trading of the shares of the Company will remain suspended on record date i.e., 14.12.2016.

Wed, 7th December 2016

6:00 pm

Q1

EPS was Tk. 0.55 for July-September, 2016 as against Tk. 1.38 for July-September, 2015; NOCFPS was Tk. 3.35 for July-September, 2016 as against Tk. 3.16 for July-September, 2015. NAV per share was Tk. 25.37 as of September 30, 2016 and Tk. 24.82 as of June 30, 2016.

Thu, 1st December 2016

10:20 am

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on December 06, 2016 at 3:15 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.

Wed, 23rd November 2016

11:22 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (23.11.2016) following its corporate declaration.

Wed, 23rd November 2016

11:21 am

Dividend Declaration

The Board of Directors has recommended 26% cash dividend for the 18 months period from January 01, 2015 to June 30, 2016. Date of AGM: 29.12.2016, Time: 10:00 AM, Venue: 184/1 Tejgaon Industrial Area, Dhaka-1208. Record date: 14.12.2016.The Company reported EPS of Tk. 3.41 and NOCFPS of Tk. 12.06 for the 18 months period from January 01, 2015 to June 30, 2016. The Company has also reported EPS of Tk. 2.71 and NOCFPS of Tk. 11.59 for the 12 months period from January 01, 2015 to December 31, 2015 whereas Tk. 0.70, and Tk. 0.47 respectively for the 6 months period from January 01, 2016 to June 30, 2016. NAV per share of Tk. 24.82 as of June 30, 2016 and Tk. 24.12 as of December 31, 2015.

Thu, 17th November 2016

4:28 pm

Board Meeting

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 22, 2016 at 3:15 PM to consider, among others, audited financial statements of the Company for the 18 months period from January 01, 2015 to June 30, 2016.

Mon, 29th August 2016

10:22 am

Response by the Company of DSE Letter

In response to a DSE letter dated August 28, 2016, the Company has sent the following message to the investors of the Capital Market: "We herewith inform you that in this price hike of shares, we do not have any undisclosed material decision/information that might have impact on unusual upward movement in price hike and trading of volume of shares of Ambee Pharmaceuticals Ltd."

Mon, 8th August 2016

2:29 pm

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Mon, 27th June 2016

2:18 pm

Land Purchase

The Company has informed that the Board of Directors has decided to purchase 12 Bigha land at Gazipur with a total value of Tk. 4.26 crore.

Mon, 9th May 2016

4:55 pm

Change of Financial year

The Company has informed that the Board of Directors of the Company has decided, according to the Companies Act, 1994 and the BSEC Directive Dated April 27, 2016, to extend the Financial Year of the Company by an additional period of 6 months comprising to 18 months period ending on 30th June, 2016 instead of 31st December, 2015 in order to comply with the uniform income year from July to June as per provision of Section 9 of the Finance Act, 2015.

Mon, 4th April 2016

5:01 pm

Decision for Buying (additional information)

With reference to the Company's earlier news (disseminated by DSE on 03.04.2016), the Company has further informed that, according to negotiated Quotation price for purchase, the total price of 100 HERO Splendor Pro Motor Cycle will be Tk. 14,500,000.00 with a unit price of Tk. 145,000.00 each and the total price of 2 Iissuzu NKR55L-2016 Covered Van will be Tk. 4,600,000.00 with a unit price of Tk. 2,300,000.00 each.

Sun, 3rd April 2016

11:00 am

Decision for Buying

The Company has informed that the Board of Directors has decided to buy 100 HERO Splendor Pro Motor Cycle and 2 Iissuzu NKR55L-2016 Covered Van for the Company under Lease Finance from GSP Finance.

Wed, 24th February 2016

3:41 pm

Credit Rating Result

ARGUS Credit Rating Services Limited (ACRSL) has announced the rating of the Company as "A-" for long term and "ST-2" for short term with stable outlook in consideration of audited financials of the Company up to December 31, 2014, unaudited financials up to September 30, 2015 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Sun, 1st November 2015

12:33 pm

Q3

EPS was Tk. 1.38 for July-September, 2015 as against Tk. 1.92 for July-September, 2014; EPS was Tk. 3.10 for January-September, 2015 as against Tk. 3.51 for January-September, 2014. NOCFPS was Tk. 3.25 for January-September, 2015 as against Tk. 3.13 for January-September, 2014. NAV per share was Tk. 24.51 as of September 30, 2015 and Tk. 24.21 as of December 31, 2014.

Mon, 26th October 2015

4:44 pm

Reschedule of Board Meeting

The Company has further informed that due to unavoidable circumstances, the meeting of the Board of Directors of the Company will now be held on October 29, 2015 at 3:15 PM instead of October 28, 2015 to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2015.

Wed, 21st October 2015

4:33 pm

Board Meeting schedule under LR 16(1)

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 28, 2015 at 3:15 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on September 30, 2015.

Wed, 29th July 2015

11:56 am

Q2 Financials

EPS for April-June, 2015 was Tk. 0.95 as against Tk. 0.79 for April-June, 2014, EPS for Jan-June, 2015 was Tk. 1.72 as against Tk. 1.59 for Jan-June, 2014. NOCFPS was Tk. 1.30 for Jan-June, 2015 as against Tk. 1.10 for Jan-June, 2014. NAV per share was Tk. 25.93 as of June 30, 2015 and Tk. 24.21 as of December 31, 2014.

Mon, 25th May 2015

4:45 pm

Resumption News after Record Date

Normal trading of the shares of the Company will resume on 26.05.2015 after record date.

Wed, 20th May 2015

5:09 pm

Spot News for AGM

Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 21.05.2015 to 24.05.2015. Trading of the shares of the Company will remain suspended on record date i.e., 25.05.2015.

Wed, 13th May 2015

1:59 pm

Q1 Financials

Profit after tax from Jan15 to March15 was Tk. 1.85 million with EPS of Tk. 0.77 as against Tk. 1.91 million and Tk. 0.80 respectively for the same period of the previous year.

Mon, 11th May 2015

10:51 am

Price Limit Open

There will be no price limit on the trading of the shares of the Company today (11.05.2015) following its corporate declaration.

Mon, 11th May 2015

10:50 am

Dividend Declaration

The Board of Directors has recommended 28% cash dividend for the year ended on December 31, 2014. Date of AGM: 14.06.2015, Time: 10:00 AM, Venue: Ambee Pharmaceuticals Limited, 184/1 Tejgaon I/A, Dhaka-1208. Record Date: 25.05.2015. The Company has also reported EPS of Tk. 3.13, NAV per share of Tk. 24.21 and NOCFPS of Tk. 15.50 for the year ended on December 31, 2014.

Sun, 10th May 2015

10:06 am

Board Meeting schedule under LR 30

As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on May 10, 2015 at 3:15 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2014.

Wed, 25th March 2015

4:19 pm

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Wed, 25th February 2015

4:51 pm

Query Response

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Sun, 16th November 2014

5:08 pm

Credit Rating

ARGUS Credit Rating Services Limited (ACRSL) has announced the Rating of the Company as "A-" for long term and "ST-3" for short term with stable outlook in consideration of audited financials of the Company up to December 31, 2013, unaudited financials up to the period ending September 30, 2014 and other relevant quantitative as well as qualitative information up to the date of rating declaration.

Sun, 2nd November 2014

3:43 pm

Q3 earnings

(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2014 (July'14 to Sep'14), the Company has reported net profit after tax of Tk. 4.61 million with EPS of Tk. 1.92 as against Tk. 4.41 million and Tk. 1.84 (restated) respectively for the same period of the previous year. Whereas net profit after tax was Tk. 8.42 million with EPS of Tk. 3.51 for the period of nine months (Jan'14 to Sep'14) ended on 30.09.2014 as against Tk. 7.52 million and Tk. 3.13 (restated) respectively for the same period of the previous year.

Thu, 24th July 2014

4:03 pm

H/Y Earnings

(H/Y): As per un-audited half yearly accounts as on 30.06.2014 (Jan'14 to June'14), the Company has reported net profit after tax of Tk. 3.81 million with EPS of Tk. 1.59 as against Tk. 3.11 million and Tk. 1.30 (restated) respectively for the same period of the previous year. Whereas net profit after tax was Tk. 1.89 million with EPS of Tk. 0.79 for the period of 3 months (Apr'14 to June'14) ended on 30.06.2014 as against Tk. 1.78 million and Tk. 0.74 (restated) respectively for the same period of the previous year.

Wed, 28th May 2014

2:55 pm

trade resume

Normal trading of the shares of the Company will resume on 29.05.2014 after record date.

Tue, 27th May 2014

3:01 pm

trade suspension

Trading of the shares of the Company will remain suspended on record date i.e., 28.05.2014.

Sun, 25th May 2014

1:03 pm

Spot Market Transaction

Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 26.05.2014 to 27.05.2014. Trading of the shares of the Company will remain suspended on record date i.e., 28.05.2014.

Sun, 18th May 2014

1:57 pm

Q1 Earnings

As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2014 (Jan'14 to March'14), the Company has reported net profit after tax of Tk. 1.91 million with basic EPS of Tk. 0.96 as against Tk. 1.33 million and Tk. 0.66 respectively for the same period of the previous year. However, considering proposed bonus share @ 20% for the year 2013, restated basic EPS will be Tk. 0.80 as on 31.03.2014 and Tk. 0.55 as on 31.03.2013.

Sun, 18th May 2014

10:30 am

recommended 15% cash and 20% stock dividend

The Board of Directors has recommended 15% cash dividend and 20% stock dividend for the year ended on December 31, 2013. Date of AGM: 16.06.2014, Time: 10:00 AM, Venue: Trust Milonayaton, Dhaka-1206. Record Date: 28.05.2014. The Company has also reported EPS of Tk. 3.95, NAV per share of Tk. 26.80 and NOCFPS of Tk. 1.06 for the year ended on December 31, 2013.

Wed, 14th May 2014

2:54 pm

Board of Directors will be held on May 15, 2014

As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on May 15, 2014 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2013.

Mon, 21st April 2014

4:40 pm

Head Office been shifted

The Company has informed that the Head Office of the Company has been shifted to its new location at 184/1, Tejgaon Industrial Area Tejgaon, Dhaka-1208.

Sun, 3rd November 2013

12:50 pm

Q3

(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2013 (July'13 to Sep'13), the Company has reported net profit after tax of Tk. 4.41 million with EPS of Tk. 2.20 as against Tk. 4.67 million and Tk. 2.34 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 7.52 million with EPS of Tk. 3.76 for the period of nine months (Jan'13 to Sep'13) ended on 30.09.2013 as against Tk. 7.65 million and Tk. 3.83 respectively for the same period of the previous year.

Wed, 31st July 2013

11:25 am

Q2 Earnings

(H/Y): As per un-audited half yearly accounts as on 30.06.2013 (Jan'13 to June'13), the Company has reported net profit after tax of Tk. 3.11 million with EPS of Tk. 1.56 as against Tk. 2.98 million and Tk. 1.49 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 1.78 million with EPS of Tk. 0.89 for the period of 3 months (Apr'13 to June'13) ended on 30.06.2013 as against Tk. 1.71 million and Tk. 0.86 respectively for the same period of the previous year.

Tue, 4th June 2013

1:47 pm

CSE Query

In response to a CSE query dated June 03, 2013, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.

Mon, 13th May 2013

2:52 pm

trade suspension

Trading of the shares of the Company will remain suspended on record date i.e., 14.05.2013.

Wed, 8th May 2013

5:13 pm

Spot Market Trading

Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 09.05.2013 to 13.05.2013. Trading of the shares of the Company will remain suspended on record date i.e., 14.05.2013.

Sun, 5th May 2013

11:50 am

Q1 Earnings

As per un-audited quarterly accounts for the 1st quarter ended on 31st March 2013 (Jan'13 to Mar'13), the Company has reported net profit after tax of Tk. 1.33 million with EPS of Tk. 0.66 as against Tk. 1.27 million and Tk. 0.63 respectively for the same period of the previous year.

Thu, 25th April 2013

5:02 pm

Price limit

There will be no price limit on the trading of the shares of the Company on 28.04.2013 following its corporate declaration.

Thu, 25th April 2013

5:02 pm

Corporate Declaration

The Board of Directors has recommended cash dividend @ 33% (i.e. Tk. 3.30 per share of Tk. 10.00 each) for the year ended on December 31, 2012. Date of AGM: 30.05.2013, Time: 10:00 AM, Venue: House No. 1, Road No. 71, Gulshan Avenue-2, Dhaka-1212. Record date: 14.05.2013. The Company has also reported EPS of Tk. 3.94, NAV per share of Tk. 26.15 and NOCFPS of Tk. 5.87 for the year ended on December 31, 2012.

Wed, 24th April 2013

3:19 pm

Board meeting

As per Regulation 30 of DSE Listing Regulations, the Company has informed that a meeting of the Board of Directors will be held on April 25, 2013 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on December 31, 2012

Sun, 4th November 2012

10:53 am

Q3 Earnings 2012

As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2012 (July'12 to Sep'12), the Company has reported net profit after tax of Tk. 4.67 million with EPS of Tk. 2.34 as against Tk. 2.64 million and Tk. 1.32 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 7.65 million with EPS of Tk. 3.83 for the period of nine months (Jan'12 to Sep'12) ended on 30.09.2012 as against Tk. 4.11 million and Tk. 2.05 respectively for the same period of the previous year.

Mon, 14th May 2012

7:34 pm

- Normal trading of the shares...

Normal trading of the shares of the Company will resume on 15.05.2012 after record date.

Tue, 8th May 2012

10:09 pm

- Trading of the shares...

Trading of the shares of the Company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 09.05.2012 to 13.05.2012. Trading of the shares of the Company will remain suspended on record date i.e., 14.05.2012.

Mon, 31st October 2011

4:27 pm

- As per un-audited...

(Q3): As per un-audited quarterly accounts for the 3rd quarter ended on 30th September 2011 (July'11 to Sep'11), the Company has reported net profit after tax of Tk. 2.64 million with EPS of Tk. 1.32 as against Tk. 2.44 million and Tk. 1.22 respectively for the same period of the previous year. Whereas net profit after tax was Tk. 4.11 million with EPS of Tk. 2.05 for the period of nine months (Jan'11 to Sep'11) ended on 30.09.11 as against Tk. 4.16 million and Tk. 2.08 respectively for the same period of the previous year

Wed, 5th October 2011

11:47 pm

- In response to a DSE query...

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike

Sun, 24th July 2011

5:31 pm

- In response to a DSE query...

In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike